Informed Consent for Phase I Oncology Trials: Form, Substance and Signature

BACKGROUND: Federal regulations state consent information should be understandable to participants; concerns have been voiced about the quality of informed consent forms (ICFs) in oncology trials. METHODS: The content of ICFs for phase I studies that were conducted at a tertiary care cancer center o...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Laeeq, Mejia, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2014
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985563/
https://www.ncbi.nlm.nih.gov/pubmed/24734147
http://dx.doi.org/10.14740/jocmr1803w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985563/
https://www.ncbi.nlm.nih.gov/pubmed/24734147
http://dx.doi.org/10.14740/jocmr1803w

Ejemplares similares